Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10706093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathways

  1999cited by this paper
• Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1*

  1999influential reference
• Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

  1999cited by this paper
• Chromosomal aberrations associated with invasion in papillary superficial bladder cancer

  1998cited by this paper
• EGF‐r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization

  1998cited by this paper
• Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland.

  1998cited by this paper
• de la Chapelle, A.

  1997cited by this paper
• Translational research studies of erbB oncogenes: selection strategies for breast cancer treatment.

  1997cited by this paper
• Competitive-Differential Polymerase Chain Reaction for Gene Dosage Estimation of erbB-1 (egfr), erbB-2, and erbB-3 Oncogenes

  1997cited by this paper
• Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

  1997cited by this paper
• Semiautomated assessment of loss of heterozygosity and replication error in tumors.

  1996cited by this paper
• Wet autoclave pretreatment for immunohistochemical demonstration of oestrogen receptors in routinely processed breast carcinoma tissue

  1995cited by this paper
• The epidermal growth factor.

  1995cited by this paper
• Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas.

  1995cited by this paper
• Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

  1994cited by this paper
• Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells.

  1993cited by this paper
• EGF receptor in neoplasia and metastasis

  1993cited by this paper
• Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and pro alpha 2 (I) collagen (COL1A2).

  1992cited by this paper
• Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.

  1992cited by this paper
• The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells.

  1990cited by this paper
• Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

  1987cited by this paper
• Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells

  1985cited by this paper

• Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)‐induced phenotypes for platinum sensitivity and long‐term survival in ovarian cancer—A study from the OVCAD consortium

  2024cites this paper
• EGFR as a stable marker of prostate cancer dissemination to bones

  2020cites this paper
• Epidermal growth factor receptor intron 1 polymorphism and microsatellite instability in sporadic colorectal cancer

  2020cites this paper
• Pets as Sentinels, Forecasters and Promoters of Human Health

  2020cites this paper
• Geschlechtsspezifische Unterschiede beim Management des kolorektalen Karzinoms

  2019cites this paper
• Canine and Feline Spontaneous Mammary Tumours as Models of Human Breast Cancer

  2019cites this paper
• Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials

  2019cites this paper
• Polymorphisms in the Bovine Tumour Necrosis Factor Receptor Type Two Gene (TNF-RII) and Cell Subpopulations Naturally Infected with Bovine Leukaemia Virus

  2019cites this paper
• Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation

  2018cites this paper
• Chromosome 7 Multiplication in EGFR-positive Lung Carcinomas Based on Tissue Microarray Analysis.

  2017cites this paper
• Lack of evidence for prognostic value of epidermal growth factor receptor intron‐1 CA repeats for oral carcinomas

  2017influential citation
• Beyond SNPs and CNV: Pharmacogenomics of Polymorphic Tandem Repeats

  2017cites this paper
• Molecular mechanisms involving prostate cancer racial disparity.

  2017cites this paper
• Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma

  2016cites this paper
• On the pharmacogenetics of non-small cell lung cancer treatment

  2016cites this paper
• pidermal growth factor receptor abnormalities in atypical eratoid / rhabdoid tumors and an unusual case with gene mplification

  2016cites this paper
• Association of Polymorphisms in Connective Tissue Growth Factor and Epidermal Growth Factor Receptor Genes With Human Longevity

  2016cites this paper
• Cat Mammary Tumors: Genetic Models for the Human Counterpart

  2016cites this paper
• Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma.

  2016cites this paper
• Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.

  2015cites this paper
• Loss of heterozygosity in tumor tissue in hormonal receptor genes is associated with poor prognostic criteria in breast cancer.

  2015cites this paper
• Veränderung des Epidermal Growth Factor Receptors (EGFR) bei Sarkomen

  2015cites this paper
• Shorter EGFR Dinucleotide Repeat Length Predicts Better Response of Patients with Advanced Non-small Cell Lung Cancer to EGFR Tyrosine Kinase Inhibitor

  2015cites this paper
• ERBB2 and TWIST1 genes survey in cat mammary tumours: nucleic acids sequences and expression changes

  2015cites this paper
• Klinisch relevante, geschlechtsspezifische Unterschiede beim kolorektalen Karzinom (KRK)

  2015cites this paper
• Pharmacology and Clinical Development of New Molecularly Targeted Agents

  2015cites this paper
• Epidermal growth factor receptor abnormalities in atypical teratoid / rhabdoid tumors and an unusual case with gene amplificat

  2014cites this paper
• EGFR protein expression and gene amplification in squamous intraepithelial lesions and squamous cell carcinomas of the cervix.

  2014cites this paper
• Pharmacogénétique et thérapies ciblées

  2014cites this paper
• Polymorphisms in Genes of Drug Targets and Metabolism

  2014cites this paper
• A Disintegrin and Metalloproteinase-12 as a New Target for Cancer Treatment

  2014cites this paper
• EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer

  2014cites this paper
• Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer

  2014influential citation
• Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations.

  2014cites this paper
• Pharmacogenetics of non-small cell lung cancer (NSCLC): time to "work it out"?

  2014cites this paper
• Genetic Variants of EGF and VEGF Predict Prognosis of Patients with Advanced Esophageal Squamous Cell Carcinoma

  2014cites this paper
• STAT6 - polymorphisms, haplotypes and epistasis in relation to atopy and asthma.

  2013cites this paper
• Pharmacogenomics and Personalized Medicine for Cancer

  2013cites this paper
• Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action.

  2013cites this paper
• ERBB2 in Cat Mammary Neoplasias Disclosed a Positive Correlation between RNA and Protein Low Expression Levels: A Model for erbB-2 Negative Human Breast Cancer

  2013cites this paper
• Mature Microsatellites: Mechanisms Underlying Dinucleotide Microsatellite Mutational Biases in Human Cells

  2013cites this paper
• Associations Between Genetic Polymorphisms of Epidermal Growth Factor Receptor (EGFR) and Survival of Colorectal Cancer (CRC) Patients Treated with 5-Fluorouracil-Based Chemotherapy

  2013cites this paper
• Epidermal growth factor receptor abnormalities in atypical teratoid/rhabdoid tumors and an unusual case with gene amplification.

  2013cites this paper
• Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer.

  2013cites this paper
• Polymorphisms to predict outcome to the tyrosine kinase inhibitors gefitinib, erlotinib, sorafenib and sunitinib.

  2012cites this paper
• Relapsing high grade mucoepidermoid carcinoma

  2012cites this paper
• Microsatellite polymorphism in the EGFR, NOTCH4 and E2F4 genes and their association with breast cancer risk

  2012cites this paper
• Systemic therapies for pancreatic cancer--the role of pharmacogenetics.

  2012cites this paper
• Pharmacogenomics in Developing Asian Countries

  2012cites this paper
• EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity.

  2012cites this paper
• Abstract. Cumulative evidence indicates that epidermal growth factor receptor (EGFR) is one of the most commonly altered genes in human cancer, via overexpression, amplification and mutation. Targeted inhibition of EGFR activity suppresses signal transduction pathways which control tumor cell growth

  2012cites this paper
• Impact of EGFR Gene Polymorphisms on Anticancer Drug Cytotoxicity In Vitro

  2012cites this paper
• Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplification.

  2011cites this paper
• Epidermal Growth Factor Receptor in Pancreatic Cancer

  2011cites this paper
• Polymorphism in Epidermal Growth Factor Receptor Intron 1 Predicts Prognosis of Patients with Esophageal Cancer after Chemoradiation and Surgery

  2011cites this paper
• Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome

  2011cites this paper
• Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer

  2011cites this paper
• The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells.

  2011cites this paper
• Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.

  2011cites this paper
• Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.

  2011cites this paper
• The status of EGFR CA SSR1 is a potential prognostic factor for patients with oral squamous cell carcinoma.

  2011cites this paper
• Toxicity as a biomarker of efficacy of molecular targeted therapies: focus on EGFR and VEGF inhibiting anticancer drugs.

  2011cites this paper
• Climate change and health: a challenge for epidemiology and public health

  2010cites this paper
• A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk

  2010cites this paper
• Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma.

  2010cites this paper
• Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapies.

  2010cites this paper
• Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

  2010cites this paper
• Pharmacological inhibition of EGFR signaling enhances G-CSF–induced hematopoietic stem cell mobilization

  2010cites this paper
• Cetuximab: from bench to bedside.

  2010cites this paper
• Drug delivery and drug resistance: EGFR-tyrosine kinase inhibitors in non-small cell lung cancer

  2010cites this paper
• A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

  2009cites this paper
• EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment.

  2009cites this paper
• Lung cancer susceptibility among atomic bomb survivors in relation to CA repeat number polymorphism of epidermal growth factor receptor gene and radiation dose.

  2009cites this paper
• Epidermal growth factor receptor gene polymorphisms, R497K, but not (CA)n repeat, is associated with dilated cardiomyopathy.

  2009cites this paper
• EGFR-targeted therapies in lung cancer: predictors of response and toxicity.

  2009cites this paper
• [Cutaneous side effects of EGF receptor inhibitors].

  2009cites this paper
• Molecular mechanisms involving prostate cancer racial disparity.

  2009cites this paper
• Skin toxicities associated with epidermal growth factor receptor inhibitors

  2009cites this paper
• Intron 1 Polymorphism, Mutation and the Protein Expression of Epidermal Growth Factor Receptor in Relation to the Gefitinib Sensitivity of Korean Lung Cancer Patients

  2009cites this paper
• Targeting EGFR resistance networks in head and neck cancer.

  2009cites this paper
• Untersuchungen zur Struktur eines Amplikons im Intron 1 des humanen epidermalen Wachstumsfaktor Rezeptors: Erstmutation in der Mammakarzinom-Entstehung

  2009cites this paper
• Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib

  2008cites this paper
• Früher Verlust der Heterozygotie auf Chromosomenarm 16q in flachen epithelialen Atypien der Brust

  2008cites this paper
• Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (EGFR) in high grade central osteosarcomas

  2008cites this paper
• Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.

  2008influential citation
• Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.

  2008cites this paper
• The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.

  2008cites this paper
• Frequent mutations of the CA simple sequence repeat in intron 1 of EGFR in mismatch repair-deficient colorectal cancers.

  2008cites this paper
• EGFR inhibition as a therapy for head and neck squamous cell carcinoma.

  2008cites this paper
• Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.

  2008cites this paper
• Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer

  2008cites this paper
• Germline Polymorphisms in EGFR and Survival in Patients With Lung Cancer Receiving Gefitinib

  2008cites this paper
• [Genetic predeterminations of head and neck cancer].

  2008cites this paper
• Association Between the Length of a CA Dinucleotide Repeat in the EGFR and Risk of Breast Cancer

  2008cites this paper
• Exon 19 of EGFR mutation in relation to the CA‐repeat polymorphism in intron 1

  2008cites this paper
• Cancer drug resistance

  2008cites this paper
• Uwarunkowania genetyczne nowotworów głowy i szyi* Genetic predeterminations of head and neck cancer

  2008cites this paper
• Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients

  2008cites this paper
• EGFR inhibition as a therapy for head and neck squamous cell carcinoma

  2008cites this paper
• Screening and Validation of Dinucleotide Repeats in Intron 1 of the Human EGFR Gene and its Paralog in the HER2 Gene

  2008cites this paper